Perceptive Advisors Llc's Net Worth
Perceptive Advisors Llc's net worth is estimated to be at least $658,190,778.39 as of 07/13/2025. CoreStreet's estimation of Perceptive Advisors Llc's net worth is based on their sale of stock and current holding of stock.
Perceptive Advisors Llc is Major Shareholder at Acrivon Therapeutics, Inc. Common Stock. They have executed at least 134 trades of stock as per SEC Form 4 filings. Their most recent trade was for 437,881 units of ACRV stock on 04/30/2025. Their biggest sale was on 12/01/2021 when they sold 2,707,463 units of VBI Vaccines Inc stock for $8,961,702.53. They typically trade 10 times per year.
Total value of insider buys:
- $591,409,740.98
Total value of insider sells:
- $66,781,037.41
Most recent insider trade:
- April 30, 2025
Perceptive Advisors Llc's Insider Trading History
| Acrivon Therapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 30, 2025 | Major Shareholder | 437,881 | $1.41 | Sell | $617,412.21 |
April 28, 2025 | Major Shareholder | 215,283 | $1.56 | Sell | $335,841.48 |
April 25, 2025 | Major Shareholder | 1,054,669 | $1.95 | Sell | $2,056,604.55 |
April 11, 2024 | Major Shareholder | 2,353,000 | $8.50 | Buy | $20,000,500.00 |
| Aldeyra The | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 3, 2025 | Major Shareholder | 3,400,000 | $1.42 | Sell | $4,828,000.00 |
April 5, 2024 | Major Shareholder | 37,712 | $4.74 | Buy | $178,754.88 |
April 3, 2024 | Major Shareholder | 309,847 | $4.09 | Buy | $1,267,274.23 |
April 1, 2024 | Major Shareholder | 8,374 | $3.25 | Buy | $27,215.50 |
Oct. 18, 2023 | Major Shareholder | 306,499 | $1.74 | Sell | $533,308.26 |
Oct. 16, 2023 | Major Shareholder | 2,450,000 | $1.60 | Sell | $3,920,000.00 |
Aug. 10, 2022 | Major Shareholder | 15,000 | $7.85 | Buy | $117,750.00 |
Aug. 8, 2022 | Major Shareholder | 97,000 | $7.24 | Buy | $702,280.00 |
Aug. 3, 2022 | Major Shareholder | 100,000 | $5.84 | Buy | $584,000.00 |
Aug. 1, 2022 | Major Shareholder | 144,185 | $5.05 | Buy | $728,134.25 |
July 28, 2022 | Major Shareholder | 119,392 | $5.00 | Buy | $596,960.00 |
May 3, 2021 | Major Shareholder | 1,200,000 | $12.50 | Buy | $15,000,000.00 |
Jan. 19, 2021 | Major Shareholder | 1,368,421 | $9.50 | Buy | $12,999,999.50 |
Jan. 7, 2021 | Major Shareholder | 500,000 | $8.13 | Buy | $4,065,000.00 |
July 9, 2020 | Major Shareholder | 3,200,000 | $4.25 | Buy | $13,600,000.00 |
Feb. 14, 2017 | Major Shareholder | 893,025 | $4.50 | Buy | $4,018,612.50 |
May 26, 2016 | Major Shareholder | 700,000 | $5.00 | Buy | $3,500,000.00 |
Oct. 26, 2015 | Major Shareholder | 50,000 | $6.46 | Buy | $323,000.00 |
Oct. 22, 2015 | Major Shareholder | 18,020 | $6.47 | Buy | $116,589.40 |
Oct. 20, 2015 | Major Shareholder | 37,145 | $6.39 | Buy | $237,356.55 |
| MeiraGTx Holdings PLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 12, 2024 | Director | 1,250,000 | $4.00 | Buy | $5,000,000.00 |
| Astria Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 1, 2024 | Director | 2,481,350 | $12.09 | Buy | $29,999,521.50 |
Dec. 21, 2023 | Director | 740,000 | $6.20 | Buy | $4,588,000.00 |
Oct. 16, 2023 | Director | 1,074,608 | $6.51 | Buy | $6,995,698.08 |
Dec. 19, 2022 | Director | 908,265 | $11.01 | Buy | $9,999,997.65 |
| Solid Biosciences LLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 11, 2024 | Director | 3,410,713 | $5.53 | Buy | $18,861,242.89 |
March 23, 2021 | Director | 2,608,695 | $5.75 | Buy | $14,999,996.25 |
| Athira Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 29, 2023 | Director | 163,954 | $2.38 | Buy | $390,210.52 |
Dec. 27, 2023 | Director | 32,134 | $2.28 | Buy | $73,265.52 |
June 29, 2022 | Director | 270,000 | $2.99 | Buy | $807,300.00 |
Jan. 25, 2021 | Director | 311,111 | $22.50 | Buy | $6,999,997.50 |
| Verrica Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 28, 2023 | Major Shareholder | 126,116 | $7.08 | Buy | $892,901.28 |
Dec. 26, 2023 | Major Shareholder | 54,652 | $6.49 | Buy | $354,691.48 |
Dec. 21, 2023 | Major Shareholder | 200,000 | $6.17 | Buy | $1,234,000.00 |
Dec. 18, 2023 | Major Shareholder | 456,923 | $5.41 | Buy | $2,471,953.43 |
Dec. 15, 2023 | Major Shareholder | 500,000 | $5.97 | Buy | $2,985,000.00 |
July 5, 2022 | Major Shareholder | 1,428,571 | $2.10 | Buy | $2,999,999.10 |
| CARGO Therapeutics Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 14, 2023 | Major Shareholder | 666,666 | $15.00 | Buy | $9,999,990.00 |
| Cerevel Therapeutics Holdings Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 16, 2023 | Director | 876,808 | $22.81 | Buy | $19,999,990.48 |
Aug. 16, 2022 | Director | 1,425,000 | $35.00 | Buy | $49,875,000.00 |
Aug. 25, 2021 | Director | 61,387 | $28.57 | Buy | $1,753,826.59 |
Aug. 23, 2021 | Director | 44,437 | $25.78 | Buy | $1,145,585.86 |
July 7, 2021 | Director | 200,000 | $25.00 | Buy | $5,000,000.00 |
| Soleno Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 28, 2023 | Major Shareholder | 250,000 | $20.00 | Buy | $5,000,000.00 |
Sept. 26, 2023 | Major Shareholder | 616,789 | $16.40 | Buy | $10,115,339.60 |
June 5, 2023 | Major Shareholder | 78,468 | $5.98 | Buy | $469,238.64 |
June 1, 2023 | Major Shareholder | 7,500 | $5.59 | Buy | $41,925.00 |
May 30, 2023 | Major Shareholder | 17,500 | $5.34 | Buy | $93,450.00 |
May 26, 2023 | Major Shareholder | 22,500 | $5.27 | Buy | $118,575.00 |
May 24, 2023 | Major Shareholder | 25,000 | $5.48 | Buy | $137,000.00 |
May 22, 2023 | Major Shareholder | 27,300 | $5.12 | Buy | $139,776.00 |
May 19, 2023 | Major Shareholder | 25,200 | $4.62 | Buy | $116,424.00 |
| Lyra Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 31, 2023 | Director | 3,610,832 | $2.49 | Buy | $8,990,971.68 |
| VBI Vaccines Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 6, 2023 | Major Shareholder | 212,578 | $2.20 | Sell | $467,671.60 |
April 4, 2023 | Major Shareholder | 4,810,623 | $0.16 | Sell | $769,699.68 |
Dec. 1, 2021 | Major Shareholder | 2,707,463 | $3.31 | Sell | $8,961,702.53 |
June 29, 2021 | Major Shareholder | 646,257 | $3.80 | Sell | $2,455,776.60 |
June 9, 2021 | Major Shareholder | 1,422,567 | $4.00 | Sell | $5,690,268.00 |
Sept. 23, 2019 | Major Shareholder | 20,000,000 | $0.50 | Buy | $10,000,000.00 |
Dec. 13, 2018 | Major Shareholder | 14,285,714 | $1.40 | Buy | $19,999,999.60 |
Dec. 6, 2016 | Major Shareholder | 3,383,955 | $3.05 | Buy | $10,321,062.75 |
Aug. 14, 2015 | Major Shareholder | 650,000 | $2.08 | Buy | $1,352,000.00 |
| Quotient Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 31, 2022 | Major Shareholder | 8,255,607 | $0.08 | Sell | $660,448.56 |
Sept. 15, 2020 | Major Shareholder | 2,911,764 | $4.25 | Buy | $12,374,997.00 |
Nov. 7, 2019 | Major Shareholder | 2,500,000 | $7.00 | Buy | $17,500,000.00 |
| Albireo Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 13, 2022 | Major Shareholder | 179,132 | $22.01 | Sell | $3,942,695.32 |
Oct. 11, 2022 | Major Shareholder | 144,065 | $23.54 | Sell | $3,391,290.10 |
Feb. 3, 2020 | Major Shareholder | 255,809 | $21.00 | Buy | $5,371,989.00 |
| LianBio ADR | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 18, 2022 | Director | 998,240 | $2.40 | Buy | $2,395,776.00 |
| Crinetics Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 18, 2022 | Major Shareholder | 157,515 | $22.22 | Buy | $3,499,983.30 |
Oct. 25, 2021 | Major Shareholder | 1,200,000 | $19.80 | Buy | $23,760,000.00 |
April 8, 2021 | Major Shareholder | 304,136 | $16.44 | Buy | $4,999,995.84 |
| Nautilus Biotechnology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 8, 2021 | Director | 200,000 | $5.36 | Buy | $1,072,000.00 |
| Agile Thrpe | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 13, 2021 | Major Shareholder | 5,734,560 | $0.85 | Buy | $4,874,376.00 |
March 13, 2020 | Major Shareholder | 1,000,000 | $1.75 | Buy | $1,750,000.00 |
Nov. 14, 2019 | Major Shareholder | 435,015 | $1.69 | Buy | $735,175.35 |
Oct. 28, 2019 | Major Shareholder | 3,815,349 | $0.51 | Sell | $1,945,827.99 |
Aug. 6, 2019 | Major Shareholder | 2,300,000 | $0.95 | Buy | $2,185,000.00 |
| Rain Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 11, 2021 | Major Shareholder | 21,826 | $12.51 | Sell | $273,043.26 |
Oct. 7, 2021 | Major Shareholder | 13,368 | $14.81 | Sell | $197,980.08 |
April 27, 2021 | Major Shareholder | 550,000 | $17.00 | Buy | $9,350,000.00 |
| ADMA Biologics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2021 | Major Shareholder | 82,505 | $1.16 | Sell | $95,705.80 |
Sept. 27, 2021 | Major Shareholder | 250,000 | $1.23 | Sell | $307,500.00 |
Sept. 23, 2021 | Major Shareholder | 780,000 | $1.27 | Sell | $990,600.00 |
Aug. 19, 2021 | Major Shareholder | 350,352 | $1.24 | Sell | $434,436.48 |
Aug. 17, 2021 | Major Shareholder | 879,092 | $1.35 | Sell | $1,186,774.20 |
March 19, 2020 | Major Shareholder | 500,000 | $2.10 | Buy | $1,050,000.00 |
Feb. 11, 2020 | Major Shareholder | 4,563,700 | $3.50 | Buy | $15,972,950.00 |
| Vyne Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 16, 2021 | Major Shareholder | 250,000 | $1.74 | Sell | $435,000.00 |
Aug. 12, 2021 | Major Shareholder | 338,897 | $2.23 | Sell | $755,740.31 |
May 6, 2021 | Major Shareholder | 1,000,000 | $3.67 | Sell | $3,670,000.00 |
Jan. 28, 2021 | Major Shareholder | 4,219,409 | $2.37 | Buy | $9,999,999.33 |
June 9, 2020 | Major Shareholder | 2,702,702 | $1.85 | Buy | $4,999,998.70 |
| Prometheus Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 16, 2021 | Major Shareholder | 850,000 | $19.00 | Buy | $16,150,000.00 |
| Landos Biopharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 8, 2021 | Director | 1,250,000 | $16.00 | Buy | $20,000,000.00 |
| Scynexis Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 22, 2021 | Major Shareholder | 319,000 | $8.24 | Sell | $2,628,560.00 |
Jan. 20, 2021 | Major Shareholder | 185,000 | $7.43 | Sell | $1,374,550.00 |
| Motus GI Holdings Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 22, 2021 | Major Shareholder | 550,000 | $1.48 | Sell | $814,000.00 |
Jan. 20, 2021 | Major Shareholder | 325,648 | $1.80 | Sell | $586,166.40 |
| Athenex Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 14, 2020 | Major Shareholder | 1,800,000 | $11.00 | Buy | $19,800,000.00 |
Sept. 10, 2020 | Major Shareholder | 200,000 | $11.24 | Buy | $2,248,000.00 |
Oct. 16, 2019 | Major Shareholder | 67,222 | $10.29 | Buy | $691,714.38 |
Sept. 16, 2019 | Major Shareholder | 30,000 | $13.58 | Buy | $407,400.00 |
Sept. 12, 2019 | Major Shareholder | 13,584 | $14.05 | Buy | $190,855.20 |
Aug. 15, 2019 | Major Shareholder | 30,000 | $15.00 | Buy | $450,000.00 |
June 24, 2019 | Major Shareholder | 20,786 | $17.90 | Buy | $372,069.40 |
June 21, 2019 | Major Shareholder | 23,073 | $17.85 | Buy | $411,853.05 |
May 6, 2019 | Major Shareholder | 100,000 | $12.71 | Buy | $1,271,000.00 |
| Leap Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 22, 2020 | Major Shareholder | 1,750,000 | $2.00 | Buy | $3,500,000.00 |
| Amicus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 24, 2018 | Major Shareholder | 20,000 | $12.45 | Buy | $249,000.00 |
March 5, 2018 | Major Shareholder | 335,827 | $13.56 | Buy | $4,553,814.12 |
Dec. 30, 2016 | Major Shareholder | 94,750 | $4.96 | Buy | $469,960.00 |
Dec. 29, 2016 | Major Shareholder | 142,125 | $4.87 | Buy | $692,148.75 |
Dec. 23, 2016 | Major Shareholder | 85,275 | $4.81 | Buy | $410,172.75 |
Dec. 22, 2016 | Major Shareholder | 189,500 | $4.51 | Buy | $854,645.00 |
Aug. 25, 2016 | Insider | 1,100,000 | $6.81 | Sell | $7,491,000.00 |
Oct. 7, 2015 | Major Shareholder | 50,000 | $6.27 | Buy | $313,500.00 |
Oct. 6, 2015 | Major Shareholder | 750,000 | $6.71 | Buy | $5,032,500.00 |
Nov. 19, 2014 | Major Shareholder | 2,100,000 | $6.50 | Buy | $13,650,000.00 |
June 30, 2014 | Major Shareholder | 4,000,000 | $3.50 | Buy | $14,000,000.00 |
| Global Blood Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 19, 2017 | Major Shareholder | 175,000 | $38.00 | Buy | $6,650,000.00 |
| AcelRx Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2016 | Major Shareholder | 216,500 | $3.92 | Sell | $848,680.00 |
Sept. 15, 2016 | Major Shareholder | 392,850 | $3.70 | Sell | $1,453,545.00 |
Nov. 18, 2015 | Major Shareholder | 176,200 | $5.35 | Sell | $942,670.00 |
Nov. 6, 2015 | Major Shareholder | 92,100 | $4.59 | Sell | $422,739.00 |
Sept. 9, 2015 | Major Shareholder | 310,000 | $4.18 | Sell | $1,295,800.00 |
Nov. 7, 2013 | major shareholder | 200,000 | $6.51 | Buy | $1,302,000.00 |
Nov. 4, 2013 | major shareholder | 155,000 | $6.87 | Buy | $1,064,850.00 |
Nov. 1, 2013 | Major Shareholder | 360,660 | $6.91 | Buy | $2,492,160.60 |
July 23, 2013 | Major Shareholder | 850,000 | $11.65 | Buy | $9,902,500.00 |